Publication

Understanding and measuring human B-cell tolerance and its breakdown in autoimmune disease

Downloadable Content

Persistent URL
Last modified
  • 08/19/2025
Type of Material
Authors
    Kevin S. Cashman, Emory UniversityScott Jenks, Emory UniversityMatthew Woodruff, Emory UniversityDeepak Tomar, Emory UniversityChristopher Tipton, Emory UniversityChristopher Scharer, Emory UniversityFrances Eun-Hyung Lee, Emory UniversityJeremy Boss, Emory UniversityIgnacio Sanz, Emory University
Language
  • English
Date
  • 2019-11-22
Publisher
  • WILEY
Publication Version
Copyright Statement
  • © 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 292
Issue
  • 1
Start Page
  • 76
End Page
  • 89
Grant/Funding Information
  • Funding support was provided by the National Institutes of Health (Sanz: U19-AI110483 Autoimmunity Center of Excellence, R37-AI049660; Lee: P01-AI078907, R01-AI121252, and U19-AI109962.; Sanz/Lee: P01-AI125180; Woodruff: T32-DK007656) and the United States-Israel Binational Science Foundation (Sanz: BSF-2013432)
Abstract
  • The maintenance of immunological tolerance of B lymphocytes is a complex and critical process that must be implemented as to avoid the detrimental development of autoreactivity and possible autoimmunity. Murine models have been invaluable to elucidate many of the key components in B-cell tolerance; however, translation to human homeostatic and pathogenic immune states can be difficult to assess. Functional autoreactive, flow cytometric, and single-cell cloning assays have proven to be critical in deciphering breaks in B-cell tolerance within autoimmunity; however, newer approaches to assess human B-cell tolerance may prove to be vital in the further exploration of underlying tolerance defects. In this review, we supply a comprehensive overview of human immune tolerance checkpoints with associated mechanisms of enforcement, and highlight current and future methodologies which are likely to benefit future studies into the mechanisms that become defective in human autoimmune conditions.
Author Notes
  • Ignacio Sanz, M.D., Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Emory University, Atlanta, GA 30322, ignacio.sanz@emory.edu
Keywords

Tools

Relations

In Collection:

Items